Abstract:Background: While food allergy (FA) has been increasingly recognized as a growing public health burden worldwide, epidemiological studies on FA in Japan are limited. Methods: This was a noninterventional, observational study using the administrative claims data from 2010 to 2019 (10 years). Patients with physician-diagnosed FA in Japan (prevalent cohort) were divided into high-risk or low-risk cohorts using adrenaline prescription. The high-risk cohort was further divided into anaphylaxis or nonanaphylaxis cohort based on the occurrence of anaphylaxis or a serious allergic reaction (SAR) during 1 year after adrenaline prescription. The primary objective was to examine yearly prevalence of FA. The secondary objectives were to describe demographics/clinical characteristics and healthcare resource utilization (HCRU), to evaluate the number of occurrences of anaphylaxis/SAR in the high-risk cohort, and the impact of anaphylaxis/SAR on HCRU. Results: The overall standardized prevalence rate was 0.325% (95% confidence interval [CI], 0.311-0.339) in 2010 and 0.797% (95% CI, 0.790-0.804) in 2019 and predominant in patients age <6 years (preschool; 3.377% [95% CI, 3.229-3.525] in 2010 and 5.726% [95% CI, 5.663-5.789] in 2019). Majority of FA patients (>80%) were children/adolescent throughout the 10 years. While high-risk cohort was a relatively minor population (8.5% in the prevalent cohort in 2019), the occurrence of anaphylaxis/SAR in the high-risk cohort was 227,690/100,000 patient-years. Multivariate analysis showed a significant increase in HCRU variables in the anaphylaxis versus nonanaphylaxis cohort (e.g., 2.08 [95% CI, 2.05-2.11] times more FA-related outpatient visits). Conclusions: Prevalence of FA increased in a statistically significant way from 2010 to 2019; 1.7-fold increase was observed in patients <6 years old. Patients in the high-risk cohort appear to have suffered from frequent anaphylaxis/SAR, highlighting an unmet medical need for FA patients at "high-risk," considering the unavailability of approved medications to prevent anaphylaxis/SAR.

Regular consumption following early introduction of allergenic foods and aggressive treatment of eczema are necessary for preventing the development of food allergy in children

Food Allergy Prevention: Early Versus Late Introduction of Food Allergens in Children

Health Promotion of Early and Sustained Allergenic Food Introduction for the Prevention of Food Allergy

Glutamine-enhanced diets in stressed rats improve nitrogen balance.

Timing of Food Introduction and Allergy Prevention: An Update

Early-life Risk Factors for Food Allergy: Dietary and Environmental Factors Revisited.

Prevention of IgE-Mediated Food Allergy: Emerging Strategies through Maternal and Neonatal Interventions

Dietary exposures and allergy prevention in high-risk infants

Preventing Food Allergy in Infancy--Early Consumption or Avoidance?

Feasibility and Safety of the Early Introduction of Allergenic Foods in Asian Infants with Eczema

Early Introduction of Food Allergens and Risk of Developing Food Allergy

Early intervention and prevention of allergic diseases

Infant feeding and the development of food allergies and atopic eczema: An update

Management of Infant Atopic Eczema to Prevent Severe Eczema and Food Allergy

Effective Ways to Prevent Allergic Diseases: Where Do We Stand?

Dependence of phosphate transport in yeast on glycolytic substrates

Peanut Allergy in Children—Is Prevention Better than Cure?

A Scheme of Independent Calculations in a Precedence Constrained Routing Problem

Prevalence of food allergy increased 1.7 times in the past 10 years among Japanese patients below 6 years of age

Primary Prevention of Allergic Diseases: The Role of Early Exposure to Cow's Milk Formula

Regulation of oral antigen delivery early in life: Implications for oral tolerance and food allergy